Group One Trading
EVOK

Group One Trading’s Evoke Pharma EVOK Stock Holding History

Group One Trading’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-425
Closed -$17K – 7705
2022
Q2 		$17K Buy
+425
New +$20.3K ﹤0.01% 6404
2022
Q1 		– Sell
-17
Closed -$1K – 8206
2021
Q4 		$1K Hold
17
– – ﹤0.01% 7980
2021
Q3 		$3K Buy
+17
New +$2.87K ﹤0.01% 7860
2021
Q2 		– Sell
-10
Closed -$3K – 8256
2021
Q1 		$3K Buy
10
+7
+233% +$2.8K ﹤0.01% 7333
2020
Q4 		$1K Buy
+3
New +$1.55K ﹤0.01% 6321

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Group One Trading's EVOK Position: Q4 2022 in Review

Group One Trading sold out of Evoke Pharma (EVOK) in Q4 2022, closing a stake of 28 shares — an estimated $1K sold.

Group One Trading first reported a position in EVOK in Q3 2020 and held it in 8 quarters. The position peaked at $89K in Q4 2020. 11 funds tracked by Wall St. Rank hold EVOK as of Q4 2022.

  • Group One Trading reported no remaining Evoke Pharma position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 28 Evoke Pharma shares in Q4 2022, an estimated $1K.
  • Group One Trading first reported a position in Evoke Pharma in Q3 2020 and held it in 8 quarters.
  • Group One Trading's Evoke Pharma position peaked at $89K in Q4 2020.
  • 11 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.